Coronavirus treatments: keep your eye on anti-complement drugs—they look promising

Many drugs are being tested in patients at different stages of the disease, but with a few notable exceptions, results so far have been disappointing. In patients with severe COVID-19, runaway inflammation is a big contributor to the tissue damage we see with this disease. Another class of drugs that you may soon be hearing more about are those targeting complement. THE CONVERSATION

Read More

Expanding marine protected areas by 5% could boost fish yields by 20% – but there’s a catch

A new study argues that by expanding the world’s MPAs by just 5% could generate an extra nine to 12 million tonnes of seafood per year, worth between USD$15-19 billion. It would also significantly increase how much nutritious fish protein is available for a growing human population to eat. THE CONVERSATION

Read More